These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 22985658
1. Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. Verrier RL, Pagotto VP, Kanas AF, Sobrado MF, Nearing BD, Zeng D, Belardinelli L. Heart Rhythm; 2013 Jan; 10(1):121-7. PubMed ID: 22985658 [Abstract] [Full Text] [Related]
2. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation. Frommeyer G, Milberg P, Uphaus T, Kaiser D, Kaese S, Breithardt G, Eckardt L. Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657 [Abstract] [Full Text] [Related]
3. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. Burashnikov A, Sicouri S, Di Diego JM, Belardinelli L, Antzelevitch C. J Am Coll Cardiol; 2010 Oct 05; 56(15):1216-24. PubMed ID: 20883928 [Abstract] [Full Text] [Related]
4. Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model. Nieminen T, Nanbu DY, Datti IP, Vaz GR, Tavares CA, Pegler JR, Nearing BD, Belardinelli L, Verrier RL. Heart Rhythm; 2011 Apr 05; 8(4):608-14. PubMed ID: 21094698 [Abstract] [Full Text] [Related]
5. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation. Justo F, Fuller H, Nearing BD, Rajamani S, Belardinelli L, Verrier RL. Heart Rhythm; 2016 Sep 05; 13(9):1860-7. PubMed ID: 27317981 [Abstract] [Full Text] [Related]
7. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits. Frommeyer G, Kaiser D, Uphaus T, Kaese S, Osada N, Rajamani S, Belardinelli L, Breithardt G, Eckardt L, Milberg P. Heart Rhythm; 2012 Dec 05; 9(12):2051-8. PubMed ID: 23044390 [Abstract] [Full Text] [Related]
8. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart. Carvas M, Nascimento BC, Acar M, Nearing BD, Belardinelli L, Verrier RL. J Cardiovasc Pharmacol; 2010 Mar 05; 55(3):286-91. PubMed ID: 20075744 [Abstract] [Full Text] [Related]
9. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL. J Cardiovasc Electrophysiol; 2009 Jul 05; 20(7):796-802. PubMed ID: 19298570 [Abstract] [Full Text] [Related]
14. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation. Fragakis N, Koskinas KC, Katritsis DG, Pagourelias ED, Zografos T, Geleris P. Am J Cardiol; 2012 Sep 01; 110(5):673-7. PubMed ID: 22621799 [Abstract] [Full Text] [Related]
15. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits. Aidonidis I, Doulas K, Hatziefthimiou A, Tagarakis G, Simopoulos V, Rizos I, Tsilimingas N, Molyvdas PA. J Cardiovasc Pharmacol Ther; 2013 Jan 01; 18(1):94-101. PubMed ID: 22872232 [Abstract] [Full Text] [Related]